JPRN-jRCT1050230104
Recruiting
未知
Survey on pulmonary hypertension clinical situation and patients' QO
Omura Junichi0 sites400 target enrollmentSeptember 27, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Omura Junichi
- Enrollment
- 400
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •For patients criteria:
- •The participating patient association and physician will evaluate patients' eligibility for data collection in the study using specified selection criteria. Any queries regarding these criteria should be discussed with the appropriate sponsor representative before survey distribution.
- •1\.Patients are male or female aged 20 to 100 years of age, inclusive
- •2\.Patients must have a confirmed diagnosis of PAH or CTEPH
- •3\.Before participating in the survey, the participant must read and acknowledge the consent form that permits data collection according to the requirements of the participant's region. By agreeing to the consent form and completing the survey, participants are indicating their consent to the data collection process.
- •For doctors criteria:
- •In order to minimize bias in physician selection, the survey will be conducted using a panel owned by a specialized survey company where physicians are listed. To collect opinions from specialists in the rare diseases PAH and CTEPH, responses will also be requested from advisory physicians of the PH Patient Association.
- •1\.Doctors who see at least one patient with pulmonary hypertension per month at their facility
- •2Before participating in the survey, participants must read and acknowledge a consent form that permits data collection in accordance with local requirements. By agreeing to the consent form and completing the survey, participants are indicating their consent to the data collection process.
Exclusion Criteria
- •For patients:
- •1\.Minors (under 20 years of age)
- •2\.Patients who are unable to understand the material provided
- •3\.Patients who have never been diagnosed or treated for PAH/CTEPH by a physician in the past
- •4\.Patients who did not properly answer the questions provided in the questionnaire
- •For doctors:
- •1\.Doctors who have not responded appropriately to the questions listed on the questionnaire forms
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Assessment of patients with pulmonary hypertension using cardiopulmonary exercise testingTo investigate cardiopulmonary responses to exercise in Thai patients with idiopathic pulmonary arterial hypertension (IPAH),systemic sclerosis-associated pulmonary arterial hypertension (SSc-associaPAH,CPETTCTR20171229001Research Affair Faculty of Medicine Khon Kaen University20
Completed
Not Applicable
Investigation of pulmonary hypertension in patients receiving tyrosine kinase inhibitorsChronic myelogenous leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemiaJPRN-UMIN000016857Kyushu university100
Recruiting
Not Applicable
Registry of patients with Pulmonary Hypertension in Southern BrazilPulmonary HypertensionC08.381.423RBR-4fhbrpIrmanda da Santa Casa de Misericórdia de Porto Alegre
Completed
Not Applicable
Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of LifeHypertension, PulmonaryPulmonary Disease, Chronic ObstructiveNCT01423071Wissenschaftliches Institut Bethanien e.V220
Not yet recruiting
Not Applicable
Pulmonary Hypertension and Chronic Kidney diseaseHealth Condition 1: N181- Chronic kidney disease, stage 1Health Condition 2: N182- Chronic kidney disease, stage 2 (mild)Health Condition 3: N183- Chronic kidney disease, stage 3 (moderate)Health Condition 4: N184- Chronic kidney disease, stage 4 (severe)Health Condition 5: N185- Chronic kidney disease, stage 5Health Condition 6: N189- Chronic kidney disease, unspecifiedHealth Condition 7: N186- End stage renal diseaseCTRI/2024/05/067547ikhil Pantbalekundri